Skip to main content

Table 1 Patients characteristics

From: Improved survival of patients with coronary artery disease and low ejection fraction with ICD implantation versus conventional therapy in a real world survey

  Control ICD p
  (n = 143) (n = 70)  
Age in years, mean (±SD) 67.9 ± 9.8 64.8 ± 9.9 0.034
Gender, women, n (%) 26 (18.2 %) 6 (8.6 %) 0.065
Coronary artery disease (CAD)    
1-vessel CAD, n (%) 16 (11.2 %) 16 (22.9 %) 0.025
2-vessel CAD, n (%) 41 (28.7) 23 (32.9) 0.531
3-vessel CAD, n (%) 86 (60.1) 31 (44.3) 0.029
Left ventricular ejection fraction (LVEF), % 29.1 ± 4.6 26.7 ± 6.3 0.006
LVEF, women, % 29.4 ± 4.5 28.7 ± 7.7  
LVEF, men, % 29.0 ± 4.7 26.5 ± 6.1  
LVEF, 1-vessel CAD, % 29.4 ± 4.2 26.3 ± 7.0  
LVEF, 2-vessel CAD, % 28.7 ± 4.7 25.2 ± 7.1  
LVEF, 3-vessel CAD, % 29.3 ± 4.7 28.1 ± 5.0  
Diabetes, n (%) 56 (39.2) 24 (34.3) 0.490
Pharmacotherapy, n (%)    
Betablockers 132 (93.0) 68 (97.1) 0.215
ACE inhibitors 110 (77.5) 59 (84.3) 0.245
ARBs 19 (13.4) 6 (8.6) 0.307
Statins 93 (65.5) 57 (81.4) 0.017
Diuretics 125 (88.0) 58 (82.9) 0.303
Antiarrhythmics (Amiodarone) 6 (4.2) 3 (4.3) 0.984
Anticoagulation 51 (35.9) 27 (38.6) 0.706
  1. Legend: ARB, Angiotensin II Receptor Blockers; CAD, coronary artery disease; ICD, implantable cardioverter defibrillator, LVEF, left ventricular ejection fraction; SD, standard deviation.